- Article metrics
- Last updated: Sun, 22 Feb 2026 20:46:04 Z
Neratinib enhances the efficacy of CDK4/6 inhibitor plus endocrine therapy in HR+/HER2-low breast cancer cell line ZR-75-1 via hsa-miR-23a-5p
Access & Citations
-
- 3597
- Article Accesses
-
- 2
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
